Cite
HARVARD Citation
Miyoshi, A. et al. (2021). Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. Journal of diabetes investigation. 12 (7), pp. 1293-1300. [Online].